Skip to main content
Investors
Media
open in a new window
Contact Us
open in a new window
|
Search
open in a new window
Company
Science & Medicine
Patients
Responsibility
Careers
IR Home
Why Invest
Events & Presentations
Corporate Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Contact the Board
Financials
Quarterly Results
Annual Reports
SEC Filings
Investor FAQs
Press Releases
Investor Contacts
Investor Emails Alerts
RSS Feeds
IR Home
Why Invest
Events & Presentations
Corporate Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Contact the Board
Financials
Quarterly Results
Annual Reports
SEC Filings
Investor FAQs
Press Releases
Investor Contacts
Investor Emails Alerts
RSS Feeds
Close
Close
Investors
Company
Product
Research & Development
Patients
Partnerships
Careers
Close
Press Releases
Normal
Press Release RSS Feed (opens in new window)
Press release year list
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
December 17, 2012
Ironwood and Forest Announce U.S. Availability of LINZESS™ (Linaclotide)
Download
PDF format download (opens in new window)
December 6, 2012
Protagonist and Ironwood Expand Peptide Drug Discovery Collaboration
Download
PDF format download (opens in new window)
November 28, 2012
Constella® (linaclotide) Approved in Europe for the Treatment of Irritable Bowel Syndrome with Constipation (IBS-C) in Adults
Download
PDF format download (opens in new window)
November 9, 2012
Ironwood Pharmaceuticals to Present at the Credit Suisse 2012 Healthcare Conference
Download
PDF format download (opens in new window)
November 1, 2012
Ironwood Pharmaceuticals to Host Webinar on Accounting Treatment for LINZESS™ (Linaclotide)
Download
PDF format download (opens in new window)
October 23, 2012
Ironwood and AstraZeneca Announce Linaclotide Collaboration for China
Download
PDF format download (opens in new window)
October 16, 2012
Ironwood Pharmaceuticals Provides Third Quarter 2012 Investor Update
Download
PDF format download (opens in new window)
October 9, 2012
Ironwood Pharmaceuticals to Host Third Quarter 2012 Investor Update Call
Download
PDF format download (opens in new window)
September 21, 2012
Linaclotide Receives Positive CHMP Opinion for the Treatment of IBS-C
Download
PDF format download (opens in new window)
September 12, 2012
Ironwood Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Download
PDF format download (opens in new window)
September 6, 2012
Ironwood Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference
Download
PDF format download (opens in new window)
August 30, 2012
Ironwood and Forest to Host Conference Call to Discuss FDA Approval of LINZESS™ (Linaclotide) for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Download
PDF format download (opens in new window)
August 30, 2012
Ironwood and Forest Announce FDA Approval of LINZESS™ (Linaclotide) for the Treatment of Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation
Download
PDF format download (opens in new window)
July 17, 2012
Ironwood Pharmaceuticals Provides Second Quarter 2012 Investor Update
Download
PDF format download (opens in new window)
July 10, 2012
Ironwood Pharmaceuticals to Host Second Quarter 2012 Investor Update Call
May 29, 2012
Ironwood Pharmaceuticals to Present at Upcoming Investor Conferences
May 14, 2012
Ironwood and Forest to Present 17 Linaclotide-Related Abstracts at Digestive Disease Week® 2012
May 8, 2012
Ironwood Pharmaceuticals to Present at Bank of America Merrill Lynch 2012 Health Care Conference
Download
PDF format download (opens in new window)
May 1, 2012
Ironwood Pharmaceuticals Provides First Quarter 2012 Investor Update
Download
PDF format download (opens in new window)
April 24, 2012
Ironwood Pharmaceuticals to Host First Quarter 2012 Investor Update Call
Download
PDF format download (opens in new window)
April 23, 2012
Ironwood and Forest Announce FDA Has Extended the Review Period for Linaclotide to September 2012
Download
PDF format download (opens in new window)
February 28, 2012
Ironwood Pharmaceuticals Provides Fourth Quarter 2011 Investor Update
Download
PDF format download (opens in new window)
February 27, 2012
Ironwood Pharmaceuticals to Present at Cowen and Company Annual Health Care Conference
Download
PDF format download (opens in new window)
February 21, 2012
Ironwood Pharmaceuticals to Host Fourth Quarter 2011 Investor Update Call
Download
PDF format download (opens in new window)
February 13, 2012
Ironwood Pharmaceuticals Announces Exercise of Over-Allotment Option in Public Offering of Common Stock
Download
PDF format download (opens in new window)
February 9, 2012
Ironwood Pharmaceuticals Prices Public Offering of Common Stock
Download
PDF format download (opens in new window)
February 8, 2012
Ironwood Announces FDA Advisory Committee Meeting Will Not Be Scheduled in Connection with New Drug Application for Linaclotide
Download
PDF format download (opens in new window)
February 8, 2012
Ironwood Pharmaceuticals Announces Proposed Public Offering of Common Stock
Download
PDF format download (opens in new window)
January 4, 2012
Ironwood Pharmaceuticals and Bionomics Announce Collaboration, Research, and License Agreement
Download
PDF format download (opens in new window)
January 3, 2012
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Download
PDF format download (opens in new window)